Clinical Study

Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot Study

Figure 2

Serum soluble vascular cell adhesion molecule-1 (sVCAM-1) in patients with SSc receiving immunosuppression determined over time shown as the percentage of healthy controls. Baseline, ; 3 months, ; 5 months, ; and 10 months, .